ORIC Pharmaceuticals (ORIC) news
Recent news
Orris Pharmaceuticals: entered clinical trial collaboration and supply agreement with Bayer to provide Darolutamide for Himalayas-1
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC) has entered into a clinical trial collaboration and supply agreement with Bayer to provide darolutamide for use in its upcoming Himalayas-1 Phase 3 global registrational trial of rinzimetostat (ORIC-944) in patients with metastatic castration-resistant…
AInvest Wire · Jul 14, 2026Orris Pharma entered clinical trial pact & supply pact with Bayer
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC) has entered into clinical trial collaboration and supply agreements with Bayer to support the ongoing Phase 1b trial of ORIC-944, a potential best-in-class PRC2 inhibitor, in combination with darolutamide for the treatment of metastatic prostate cancer .…
AInvest Wire · Jul 14, 2026Trump administration aide: Order related to historically black colleges
Trump administration aide: Order related to historically black colleges WASHINGTON, D.C. — President Trump signed an executive order on Wednesday, April 23, 2025, creating a White House initiative to empower historically Black colleges and universities (HBCUs). The new initiative is designed to…
AInvest Wire · Apr 23, 2025ORIC Pharma rated new overweight at Wells Fargo: PT $20
ORIC Pharma rated new overweight at Wells Fargo: PT $20 ORIC Pharma (Nasdaq: ORIC), a clinical-stage oncology company specializing in developing treatments that overcome cancer resistance mechanisms, recently announced its participation in several upcoming investor conferences [1]. This news has…
AInvest Wire · Oct 31, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.